Gene · 3400
ID4: inhibitor of DNA binding 4
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ID4: inhibitor of DNA binding 4. Genes, record 3400. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3400
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P47928 | DNA-binding protein inhibitor ID-4 | 161 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 49756 | P47928 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15160 | P47928 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 29794 | P47928 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15160 | P47928 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15160 | P47928 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 29794 | P47928 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 14999 | P47928 | Espacenet |
| US 11821003 B2 | 2023-11-21 | 4 | P47928 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 29794 | P47928 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 40185 | P47928 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,228
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ID4 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| R01AG070921 | Rates and mechanisms of age-related somatic mutation in normal and Alzheimer brain | 4 | 2025 |
| R01NS032457 | Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage | 4 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 3 | 2025 |
| P30CA042014 | Cancer Center Support Grant | 3 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 3 | 2025 |
1 to 10 of 1,228Source NIH's project files
See all 1,228 nih grantsPapers1,647
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk. | Gut | 2026 | 42728028 | PubTator, text mining | PubMed |
| Divergent somatic mutation patterns among human cerebellar neuron types. | Neuron | 2026 | 42575091 | PubTator, text mining | PubMed |
| GFAP-Dependent Transcriptional Dynamics and Cellular Heterogeneity in Primary, Recurrent, and Grade III Gliomas. | Cancer Inform | 2026 | 42368220 | PubTator, text mining | PubMed |
| Clonal lineage tracing of innate immune cells in human cancer. | Cancer Cell | 2026 | 42242233 | PubTator, text mining | PubMed |
| Single-cell landscape of melanoma reveals ETV5-driven C3 ID4+ tumor subpopulation with extracellular vesicle-associated immunosuppressive and pro-metastatic potential. | Front Immunol | 2026 | 42079653 | PubTator, text mining | PubMed |
| Chemotherapy Enrichment of ID Family Expression Is Associated with IL-6 Signaling in Ovarian Cancer. | Cancers (Basel) | 2026 | 42073515 | PubTator, text mining | PubMed |
| Genomic inversion at 6p22.3 supports ID4 dysregulation as the pathogenic mechanism of Mesomelic dysplasia Savarirayan-type. | Eur J Hum Genet | 2026 | 42069959 | PubTator, text mining | PubMed |
| BMP4 signaling regulates the expression of signals and transcription factors for coordinated cytodifferentiation in the murine ureter. | Biochem J | 2026 | 42017529 | PubTator, text mining | PubMed |
| Matrix-independent quantification of paracetamol in complex aquatic matrices using quadruple isotope dilution Orbitrap mass spectrometry. | Talanta | 2026 | 42001727 | PubTator, text mining | PubMed |
| New Frontiers in the Pathophysiology of Hypertensive Pregnancy Disorders: A Systematic Review of Molecular Insights into Preeclampsia. | Curr Issues Mol Biol | 2026 | 41899446 | PubTator, text mining | PubMed |
1 to 10 of 1,647
See all 1,647 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3400
GET https://conductscience.org/api/genes/v1/3400/patents?page=2